Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07215715) titled 'US Benchmarking Clinical Study' on Oct. 1.
Study Type: Observational
Primary Sponsor: eMyosound SAS
Condition:
HFpEF - Heart Failure With Preserved Ejection Fraction
HFmrEF
ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
Left Ventricular Hypertrophy
Cardiac Amyloidosis
Recruitment Status: Recruiting
Date of First Enrollment: September 16, 2025
Target Sample Size: 150
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07215715
Published by HT Digital Content Services with permission from Health Daily Digest....